Back to MW MARSHALL WACE, LLP
ALGS3 quarters
Position history for MWMARSHALL WACE, LLP's holdings in ALIGOS THERAPEUTICS INC
MARSHALL WACE, LLP holds 246,579 shares of ALGS (ALIGOS THERAPEUTICS INC), worth $1.4M as of 2026-Q2. The position was decreased (-7.7% shares). ALGS represents 0.0% of MARSHALL WACE, LLP's portfolio.
Current Value
$1.4M
Current Shares
246,579
Total Value Change
-$1.1M
Total Shares Change
-22,085
Quarter-by-Quarter History
Other major holders of ALGS: ADAGE CAPITAL PARTNERS GP, L.L.C., Woodline Partners LP, Alyeska Investment Group, L.P., VANGUARD GROUP INC